Knowledge Management System Of Institute of process engineering,CAS
| Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease | |
| Huang, Ya-ru1,2; Xie, Xi-xiu1; Ji, Mei1,2; Yu, Xiao-lin1; Zhu, Jie1; Zhang, Ling-xiao1,2; Liu, Xiao-ge1,2; Wei, Chen3; Li, Gang4; Liu, Rui-tian1 | |
| 2019-04-01 | |
| Source Publication | NEUROBIOLOGY OF DISEASE
 |
| ISSN | 0969-9961 |
| Volume | 124Pages:202-217 |
| Abstract | It has been suggested that aggregation of alpha-synuclein (alpha-syn) into oligomers leads to neurodegeneration in Parkinson's disease (PD), but intravenous immunoglobulin (IVIG) which contains antibodies against alpha-syn monomers and oligomers fails to treat PD mouse model. The reason may be because IVIG contains much low level of antibodies against alpha-syn, and of which only a small part can penetrate the blood-brain barrier, resulting in an extremely low level of effective antibodies in the brain, and limiting the beneficial effect of IVIG on PD mice. Here, we first isolated naturally occurring autoantibodies against alpha-syn (NAbs-alpha-syn) from IVIG. Our further investigation results showed that NAbs-alpha-syn inhibited alpha-syn aggregation and attenuated alpha-syn-induced cytotoxicity in vitro. Compared with vehicles, NAbs-alpha-syn significantly attenuated the memory and motor deficits by reducing the levels of soluble alpha-syn, total human alpha-syn and alpha-syn oligomers, decreasing the intracellular P-alpha-syn(ser129) deposits and axonal pathology, inhibiting the microgliosis and astrogliosis, as well as the production of proinflammatory cytokines, increasing the levels of PSD95, synaptophysin and TH in the brain of A53T transgenic mice. These findings suggest that NAbs-alpha-syn overcomes the deficiency of IVIG and exhibits a promising therapeutic potential for the treatment of PD. |
| Keyword | Parkinson's disease alpha-Synuclein Naturally occurring autoantibodies A53T mice WIG |
| DOI | 10.1016/j.nbd.2018.11.024 |
| Language | 英语 |
| WOS Keyword | INTRAVENOUS IMMUNOGLOBULIN ; ALZHEIMERS-DISEASE ; TRANSGENIC MODEL ; AGGREGATION ; IMMUNOTHERAPY ; ANTIBODIES ; OLIGOMERS ; MICE ; NEURODEGENERATION ; ACCUMULATION |
| Funding Project | Strategic Leading Project of China Academy of Sciences[XDA 12040215] ; National Science and Technology Major Projects of New Drugs[2015ZX09102015] |
| WOS Research Area | Neurosciences & Neurology |
| WOS Subject | Neurosciences |
| Funding Organization | Strategic Leading Project of China Academy of Sciences ; National Science and Technology Major Projects of New Drugs |
| WOS ID | WOS:000459217800019 |
| Publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.ipe.ac.cn/handle/122111/28087 |
| Collection | 中国科学院过程工程研究所 |
| Corresponding Author | Li, Gang; Liu, Rui-tian |
| Affiliation | 1.Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China 2.Univ Chinese Acad Sci, Sch Chem Engn, Beijing 100049, Peoples R China 3.Natl Inst Food & Drug Control, Beijing 100050, Peoples R China 4.Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, Jiefang Ave, Wuhan 430022, Hubei, Peoples R China |
| Recommended Citation GB/T 7714 | Huang, Ya-ru,Xie, Xi-xiu,Ji, Mei,et al. Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease[J]. NEUROBIOLOGY OF DISEASE,2019,124:202-217. |
| APA | Huang, Ya-ru.,Xie, Xi-xiu.,Ji, Mei.,Yu, Xiao-lin.,Zhu, Jie.,...&Liu, Rui-tian.(2019).Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease.NEUROBIOLOGY OF DISEASE,124,202-217. |
| MLA | Huang, Ya-ru,et al."Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease".NEUROBIOLOGY OF DISEASE 124(2019):202-217. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment